Recombinant IL6 (Clazakizumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects IL6 (Clazakizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7487991
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL6 (Clazakizumab Biosimilar) antibody (ABIN7487991)
Target
IL6 (Clazakizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL6 (Clazakizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Clazakizumab Biosimilar - Anti-IL6 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL6 (Clazakizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
ALD-518,BMS-945429
Clazakizumab (formerly ALD518 and BMS-945429), an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6. -
CAS-No
- 1236278-28-6
Target
-
You are here:
